Effects of Reduced Gcm1 Expression on Trophoblast Morphology, Fetoplacental Vascularity, and Pregnancy Outcomes in Mice

Authors:

Abstract
Preeclampsia is a life-threatening disorder characterized by maternal gestational hypertension and proteinuria that results from placental dysfunction. Placental abnormalities include abnormal syncytiotrophoblast and a 50% reduction in placental expression of the transcription factor Gcm1 . In mice, homozygous deletion of Gcm1 prevents syncytiotrophoblast differentiation and is embryonic lethal. We used heterozygous Gcm1 mutants ( Gcm1 +/− ) to test the hypothesis that hypomorphic expression of placental Gcm1 causes defective syncytiotrophoblast differentiation and maternal and placental phenotypes that resemble preeclampsia. We mated wild-type female mice with Gcm1 +/− fathers to obtain wild-type mothers carrying ≈50% Gcm1 +/− conceptuses. Gcm1 +/− placentas had syncytiotrophoblast abnormalities including reduced gene expression of Gcm1 -regulated SynB , elevated expression of sFlt1 , a thickened interhemal membrane separating maternal and fetal circulations, and electron microscopic evidence in syncytiotrophoblast of necrosis and impaired maternal-fetal transfer. Fetoplacental vascularity was quantified by histomorphometry and microcomputed tomography imaging. In Gcm1 +/− , it was ≈30% greater than wild-type littermates, whereas placental vascular endothelial growth factor A ( Vegfa ) expression and fetal and placental weights did not differ. Wild-type mothers carrying Gcm1 +/− conceptuses developed late gestational hypertension (118±2 versus 109.6±0.7 mm Hg in controls; P Gcm1 expression in human control and pathological pregnancies and found that, as in mice, fetoplacental vascularity increased when GCM1 protein expression decreased ( R 2 =−0.45; P Gcm1 expression as a causative factor in defective syncytiotrophoblast differentiation and maternal and placental phenotypes in preeclampsia in humans.

This publication has 36 references indexed in Scilit: